Just been looking at the healthcare sector and there's something interesting most people seem to overlook - some solid dividend plays sitting right there under $1K per share.



Becton, Dickinson is one of those stocks that doesn't grab headlines like the GLP-1 winners do, but the dividend story here is actually pretty wild. We're talking 50+ years of consecutive annual dividend increases. That's Dividend King territory, which puts it in rare company. The yield is sitting at 2.4%, which beats the market average by a decent margin.

What's happening now is kind of interesting timing-wise. The company's been going through a rough patch, but they just spun off a division that wasn't working out, and there's a new product pipeline that could shift the narrative. Management's going to have more focus now. For people thinking long-term, this could be worth watching while Wall Street's still skeptical.

Then there's Medtronic. Almost at Dividend King status itself - just a couple years away - and the dividend yield here is even more attractive at 2.9%. Similar story with the rough patch, but here's the catalyst: they've started selling surgical robots in the US market. That's potentially massive. Intuitive Surgical is trading at 63x P/E because of surgical robotics dominance, while Medtronic's sitting at 27x. Even with a more diversified business, there's room for the market to reprice this.

The practical part: $1,000 gets you five shares of Becton, Dickinson or ten shares of Medtronic. Both have near-term catalysts that could push valuations higher, so these aren't just dividend plays anymore - there's actual growth potential mixed in. Worth considering if you're building a healthcare dividend position, but the window might not stay open forever.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin